| abstract |
The invention relates to 2- (5- {1- [2- (difluoromethoxy) -6-fluorobenzyl] -2-methyl-1H-benzimidazol-6-yl} pyrimidin-2-yl) propan-2-ol or its pharmaceutically acceptable salt, which is an active modulator of human TNF activity and therefore may be useful for the treatment and / or prevention of various human diseases, including autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ophthalmic disorders and oncological disorders. |